Literature DB >> 9746602

Biological and biochemical characteristics of cytoadhesion of Plasmodium falciparum-infected erythrocytes to chondroitin-4-sulfate.

B Pouvelle1, T Fusaï, C Lépolard, J Gysin.   

Abstract

The cytoadhesion of Plasmodium falciparum laboratory strains and clones to Saimiri brain microvascular endothelial cells (SBEC 17), with chondroitin-4-sulfate (CSA) as the only adhesion receptor, was tested. Only one strain had significant cytoadhesion. However, CSA-specific infected erythrocytes (IRBCs) were detected in all strains after selection of a CSA-specific subpopulation by culturing the few adherent IRBCs. This demonstrates the lack of sensitivity of cytoadhesion microassays for detecting small quantities of CSA-specific IRBCs in cultures or field isolates. Cytoadhesion to CSA is maximal at 24 h of the cycle and decreases with the onset of schizogony, reaching a minimum just before reinvasion. This fluctuation must be taken into account in comparisons of the cytoadhesion of different strains or isolates. The minimum size of CSA for active inhibition was 4 kDa, and a mass of 9 kDa was required for inhibition similar to that obtained with the 50-kDa CSA. In contrast to cytoadhesion to CSA, which is pH independent or maximal at physiological pH (depending on the target endothelial cells), adhesion to CD36 and intercellular adhesion molecule 1 was pH dependent, requiring acidic conditions to be maximal in all cases. Cytoadhesion to CSA may trigger the occlusion of microvessels and cause the acidosis necessary for the other receptors to be fully efficient. If this key role in the mechanisms of sequestration were to be confirmed in vivo, prevalence studies of the CSA cytoadhesion phenotype would have to be reevaluated, because simple cytoadhesion assays do not detect CSA-specific parasites present in very low numbers, and these parasites might then be undetected in the peripheral blood but present in organs in which sequestration occurs, such as the placenta (M. Fried and P. E. Duffy, Science 272:1502-1504, 1996).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746602      PMCID: PMC108613     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  An improved microassay for Plasmodium falciparum cytoadherence using stable transformants of Chinese hamster ovary cells expressing CD36 or intercellular adhesion molecule-1.

Authors:  T Hasler; G R Albrecht; M R Van Schravendijk; J C Aguiar; K E Morehead; B L Pasloske; C Ma; J W Barnwell; B Greenwood; R J Howard
Journal:  Am J Trop Med Hyg       Date:  1993-03       Impact factor: 2.345

Review 2.  The molecular basis of pathogenesis of cerebral malaria.

Authors:  H Fujioka; M Aikawa
Journal:  Microb Pathog       Date:  1996-02       Impact factor: 3.738

3.  Receptor-specific adhesion and clinical disease in Plasmodium falciparum.

Authors:  C Newbold; P Warn; G Black; A Berendt; A Craig; B Snow; M Msobo; N Peshu; K Marsh
Journal:  Am J Trop Med Hyg       Date:  1997-10       Impact factor: 2.345

4.  Cytoadherence characteristics of Plasmodium falciparum isolates from Thailand: evidence for chondroitin sulfate a as a cytoadherence receptor.

Authors:  S C Chaiyaroj; P Angkasekwinai; A Buranakiti; S Looareesuwan; S J Rogerson; G V Brown
Journal:  Am J Trop Med Hyg       Date:  1996-07       Impact factor: 2.345

5.  Cytoadherence of Plasmodium falciparum to intercellular adhesion molecule 1 and chondroitin-4-sulfate expressed by the syncytiotrophoblast in the human placenta.

Authors:  B Maubert; L J Guilbert; P Deloron
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

Review 6.  [Plasmodium falciparum and chondroitin-4-sulfate: the new key couple in sequestration].

Authors:  B Pouvelle; T Fusai; J Gysin
Journal:  Med Trop (Mars)       Date:  1998

7.  Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence.

Authors:  D D Roberts; J A Sherwood; S L Spitalnik; L J Panton; R J Howard; V M Dixit; W A Frazier; L H Miller; V Ginsburg
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

8.  Genetic analysis of the human malaria parasite Plasmodium falciparum.

Authors:  D Walliker; I A Quakyi; T E Wellems; T F McCutchan; A Szarfman; W T London; L M Corcoran; T R Burkot; R Carter
Journal:  Science       Date:  1987-06-26       Impact factor: 47.728

9.  Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.

Authors:  M Fried; P E Duffy
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

10.  Clinical correlates of in vitro Plasmodium falciparum cytoadherence.

Authors:  M Ho; B Singh; S Looareesuwan; T M Davis; D Bunnag; N J White
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

View more
  16 in total

1.  Chondroitin sulfate proteoglycan but not hyaluronic acid is the receptor for the adherence of Plasmodium falciparum-infected erythrocytes in human placenta, and infected red blood cell adherence up-regulates the receptor expression.

Authors:  Arivalagan Muthusamy; Rajeshwara N Achur; Manojkumar Valiyaveettil; John J Botti; Diane W Taylor; Rose F Leke; D Channe Gowda
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

2.  Neural cell adhesion molecule, a new cytoadhesion receptor for Plasmodium falciparum-infected erythrocytes capable of aggregation.

Authors:  Bruno Pouvelle; Valéry Matarazzo; Christophe Jurzynski; Johannes Nemeth; Michael Ramharter; Geneviève Rougon; Jürg Gysin
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

3.  Characteristics of Plasmodium falciparum-infected-erythrocyte adhesion to chondroitin sulfate.

Authors:  James G Beeson
Journal:  Infect Immun       Date:  2008-06       Impact factor: 3.441

4.  Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum.

Authors:  Myriam Baratin; Sophie Roetynck; Catherine Lépolard; Christine Falk; Serge Sawadogo; Satoshi Uematsu; Shizuo Akira; Bernhard Ryffel; Jean-Gérard Tiraby; Lena Alexopoulou; Carsten J Kirschning; Jürg Gysin; Eric Vivier; Sophie Ugolini
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

Review 5.  Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies.

Authors:  Miloni Thakkar; Brijesh S
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

6.  Plasmodium falciparum infection-induced changes in erythrocyte membrane proteins.

Authors:  Albin Fontaine; Stéphanie Bourdon; Maya Belghazi; Mathieu Pophillat; Patrick Fourquet; Samuel Granjeaud; Marylin Torrentino-Madamet; Christophe Rogier; Thierry Fusai; Lionel Almeras
Journal:  Parasitol Res       Date:  2011-07-09       Impact factor: 2.289

7.  Ex vivo desequestration of Plasmodium falciparum-infected erythrocytes from human placenta by chondroitin sulfate A.

Authors:  J Gysin; B Pouvelle; N Fievet; A Scherf; C Lépolard
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

8.  Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy.

Authors:  I O'Neil-Dunne; R N Achur; S T Agbor-Enoh; M Valiyaveettil; R S Naik; C F Ockenhouse; A Zhou; R Megnekou; R Leke; D W Taylor; D C Gowda
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  Selective accumulation of mature asexual stages of Plasmodium falciparum-infected erythrocytes in the placenta.

Authors:  James G Beeson; Nishal Amin; Maxwell Kanjala; Stephen J Rogerson
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Parameterization of high magnetic field gradient fractionation columns for applications with Plasmodium falciparum infected human erythrocytes.

Authors:  Stephan Karl; Timothy M E Davis; Tim G St Pierre
Journal:  Malar J       Date:  2010-05-03       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.